Randomized Controlled Trial to Evaluate the Impact of ZYN Nicotine Pouch Products on Cigarette Usage and BoExp in Adult Smokers Over a 12-week Period
NCT ID: NCT06568900
Last Updated: 2024-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
450 participants
INTERVENTIONAL
2023-07-31
2024-08-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Nicotine Delivery, Subjective Effects, and Sensory Experiences of Tobacco Users Using Oral Nicotine Products and Electronic Cigarettes [ZYN Study]
NCT05030194
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
NCT05280769
Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study
NCT06072547
Use of Nicotine Pouches Among Daily Smokers
NCT06043362
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
(control) continue smoking their usual brand of CC
cigarette smoking
continue smoking usual brand of cigarette
tobacco flavor and unflavored options of ZYN
tobacco flavored and unflavored pouch
provide tobacco flavored and unflavored options of nicotine pouch
unrestricted flavor options of ZYN
unrestricted flavor options pouch
provide unrestricted flavor options of nicotine pouch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cigarette smoking
continue smoking usual brand of cigarette
tobacco flavored and unflavored pouch
provide tobacco flavored and unflavored options of nicotine pouch
unrestricted flavor options pouch
provide unrestricted flavor options of nicotine pouch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smokes an average of at least 10 commercially available cigarettes per day for the last 12 months.
* Interested in switching from combustible cigarettes to nicotine pouch products.
Exclusion Criteria
* Participants who currently use nicotine pouches.
* Participants with known heart disease or medical condition that may adversely affect participant safety
22 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swedish Match AB
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian E Erkkila, PhD
Role: STUDY_CHAIR
Swedish Match
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rose Research Center
Raleigh, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00070188
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.